Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Carboplatin 11pembrolizumab 10Paclitaxel 10Fluorouracil 9Oxaliplatin 8Radiotherapy 7Nivolumab 7Leucovorin 6Cisplatin 6Radiotherapy, Intensity-Modulated 5Magnetic Resonance Spectroscopy 5Taxes 4durvalumab 3Trastuzumab 3Surgical Procedures, Operative 3Capecitabine 3relatlimab 2Standard of Care 2Specimen Handling 2Radiation 2Proton Therapy 2Practice Guidelines as Topic 2Irinotecan 2Immune Checkpoint Inhibitors 2Fluorodeoxyglucose F18 2Drug Therapy 2Docetaxel 2Cetuximab 2Blood Specimen Collection 2zimberelimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Esophageal Neoplasms × Circulating Tumor DNA × Clear all
NCT04046575 2025-07-11

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Washington University School of Medicine

Phase 1 Active not recruiting
12 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡